RE: Good RNS cash until 202511 Sep 2024 13:08
Dallo bingo. Exactly this.
Surely Simbec Orion since appointment have a timeline or implementation plan and Immupharma would have to know what this is and approve it. IMM are not alone on this it's a disease afflicting vast swathes of the junior markets where "progress" is used excessively on releases. Tim doesn't read these boards but I bet the Nomad will do. There is no progress until you spell out what that progress is and how that is a development from what was the position before. Simple wordplay but now were "progress" is mentioned in the markets, its now a default pejorative term because it actually means insignificant or no actual progress. The incanthera warrants and the cash position are the only substantial bit of info to surface from those releases the rest is just guff. How many times have I seen partnerships mooted, there has been interest for years apparently but Avion so far have been the only ones prepared to throw their hats in, but they've gone quiet as well.